Transforming value real-world evidence

Real-world evidence demonstrates real therapeutic value, however identifying and gathering real-world data has its challenges, particularly in rare disease or when data is needed to be integrated from multiple markets, indications, and data sets. Tim Holbrook discusses the role of real-world evidence for transformational therapies, and the challenges to be overcome.

About Tim and Adelphi Real World:

Tim Holbrook is head of innovation at Adelphi Real World, leading its secondary data Real World Evidence team to deliver observational studies that demonstrate pharmaceutical product value. He is a specialist in ex-US data sources, RWE planning and generation using claims, administrative registries and other secondary sources of data in these regions. Tim also leads the Architect RWE planning service at Adelphi, delivering RWE planning services to clients.

Adelphi Real World – https://www.adelphirealworld.com